Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome
Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine which is the best dose of a drug known as
Dysport to give when treating one's type of upper back pain. The study will also examine the
side effects of this treatment and its overall effect on one's disorder.
Phase:
Phase 2
Details
Lead Sponsor:
Ipsen
Treatments:
abobotulinumtoxinA Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA